Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy.

cebranopadol (TRN-228) - Tris Pharma

methadone - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/38901642

Federica Benvenuti; Friedbert Weiss; Hongwu Li; Laura Soverchia; Nazzareno Cannella; Qianwei Shen; Rajesh Narendran; Roberto Ciccocioppo; Veronica Lunerti

Jun 21, 2024